Company Badge
USPTO Data Jan 1 1976 - Sep 15 2026
5 Patents
#755 in San Francisco, CA
#12,032 in California
#51,478 in US
Proteolix, Inc.
Forward Citations = 202
12 inventors:
San Francisco, CA, United States of America
Proteolix, Inc.
% Expired Patents = 20.0
CIPO Patents = 5
EPO Patents = 3
Forward Citations = 202
Loading Chart...
Loading Chart...
12 inventors (with patents filed for the assignee):
Guy J Laidig (4 out of 31 patents)
Mark Stephen Smyth (3 out of 41 patents)
Craig M Crews (2 out of 34 patents)
4. John H Musser (2 out of 113 patents)
5. Ronald T Borchardt (2 out of 7 patents)
6. Barry A Bunin (2 out of 6 patents)
7. Han-Jie Zhou (1 out of 37 patents)
8. Francesco Parlati (1 out of 21 patents)
9. Mark K Bennett (1 out of 35 patents)
10. Congcong M Sun (1 out of 6 patents)
11. Kevin D Shenk (1 out of 27 patents)
12. Monette Aujay (1 out of 5 patents)
13. John Clifford Chabala (29 patents)
14. Mark Nguyen Ho (1 patent)
15. Fabiana N Fonseca (1 patent)
5 patents:
Proteolix, Inc. is a biopharmaceutical company focused on the development of novel therapies for the treatment of cancer. The company's lead product is a proteasome inhibitor with promising results in clinical trials for multiple myeloma and other hematologic malignancies. Proteolix is dedicated to advancing the field of oncology through innovative research and strategic partnerships.
This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
5 patents (CIPO):
Please report any incorrect information to [email protected]
3 patents (EPO):
Please report any incorrect information to [email protected]